As of 2024-12-13, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (7.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -987.1%.
The range of the Relative Valuation is (4.66) - (8.06) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 24.9x | 18.3x |
| Forward P/E multiples | 11.2x - 19.4x | 18.7x |
| Fair Price | (4.66) - (8.06) | (7.68) |
| Upside | -638.0% - -1031.2% | -987.1% |
| Date | P/E |